HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia

Human leucocyte antigens (HLAs) modulate immunity to polyomavirus BK (BKV). Identification of HLAs that alter the course of infection will facilitate risk stratification, and customization of pre-emptive intervention strategies. We performed a retrospective cohort study with 998 kidney transplant patients with BKV infection status confirmed by polymerase chain reaction (PCR). Clinical parameters and donorrecipient matching for specific HLAs were examined in relation to occurrence of viremia. An emphasis was placed on donorrecipient matching rather than the actual frequency of specific HLA-alleles, since a successful immune response requires sharing of HLAs between a virus-infected target cell and the anti-viral effector cell. Using multivariate statistics, low risk of BK viremia was associated with matching of HLA-A2 [hazard ratio (HR) 0.51, 95 confidence interval (CI) 0.280.85], HLA-B44 (HR 0.31, 95 CI 0.0760.85) and HLA-DR15 (HR 0.35, 95 CI 0.0840.93) (P 0.05), whereas high risk of viremia was associated with male gender (HR 2.38, 95 CI 1.464.09, P 0.001). HLAs that associated with a lower predisposition to the development of BK viremia have been identified. Evaluation of donorrecipient mismatching for these HLAs could potentially be used to (i) fine tune virus screening strategies for BKV in individual patients and (ii) facilitate discovery of major histocompatibility complex (MHC) class I and II binding peptides that can elicit clinically meaningful BKV-specific immunity.